Prospective association of white matter hyperintensity volume and frailty in older adults

Andrieu, 2017, Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial, Lancet Neurol., 16, 377, 10.1016/S1474-4422(17)30040-6 Avila-Funes, 2017, Vascular cerebral damage in frail older adults: the AMImage study, J. Gerontol. A Biol. Sci. Med. Sci., 72, 971, 10.1093/gerona/glw347 Bandeen-Roche, 2015, Frailty in older adults: a nationally representative profile in the United States, J. Gerontol. A Biol. Sci. Med. Sci., 70, 1427, 10.1093/gerona/glv133 Callisaya, 2015, Progression of white matter hyperintensities of presumed vascular origin increases the risk of falls in older people, J. Gerontol. A Biol. Sci. Med. Sci., 70, 360, 10.1093/gerona/glu148 Chen, 2015, Reduced cerebellar gray matter is a neural signature of physical frailty, Hum. Brain Mapp., 36, 3666, 10.1002/hbm.22870 Christensen, 2009, Ageing populations: the challenges ahead, Lancet, 374, 1196, 10.1016/S0140-6736(09)61460-4 Chung, 2016, Cerebral microbleeds are associated with physical frailty: a community-based study, Neurobiol. Aging, 44, 143, 10.1016/j.neurobiolaging.2016.04.025 Del Brutto, 2017, Neuroimaging signatures of frailty: a population-based study in community-dwelling older adults (the Atahualpa Project), Geriatr Gerontol Int, 17, 270, 10.1111/ggi.12708 Fanning, 2014, The epidemiology of silent brain infarction: a systematic review of population-based cohorts, BMC Med., 12, 119, 10.1186/s12916-014-0119-0 Fried, 2001, Frailty in older adults: evidence for a phenotype, J. Gerontol. A Biol. Sci. Med. Sci., 56, M146, 10.1093/gerona/56.3.M146 Garcia-Nogueras, 2017, Use of health resources and healthcare costs associated with frailty: the FRADEA study, J. Nutr. Health Aging, 21, 207, 10.1007/s12603-016-0727-9 Inzitari, 2009, Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort, BMJ, b2477, 339 Moon, 2018, Prospective associations between white matter hyperintensities and lower extremity function, Neurology, 90, e1291, 10.1212/WNL.0000000000005289 Morley, 2013, Frailty consensus: a call to action, J. Am. Med. Dir. Assoc., 14, 392, 10.1016/j.jamda.2013.03.022 Newman, 2001, Associations of subclinical cardiovascular disease with frailty, J. Gerontol. A Biol. Sci. Med. Sci., 56, M158, 10.1093/gerona/56.3.M158 Rockwood, 2004, Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging, J. Gerontol. A Biol. Sci. Med. Sci., 59, 1310, 10.1093/gerona/59.12.1310 Schmidt, 2003, Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study, Lancet, 361, 2046, 10.1016/S0140-6736(03)13616-1 Siejka, 2018, Frailty and cerebral small vessel disease: a cross-sectional analysis of the Tasmanian Study of Cognition and Gait (TASCOG), J. Gerontol. A Biol. Sci. Med. Sci., 73, 255, 10.1093/gerona/glx145 Silbert, 2008, Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline, Neurology, 71, 108, 10.1212/01.wnl.0000316799.86917.37 Soumare, 2009, White matter lesions volume and motor performances in the elderly, Ann. Neurol., 65, 706, 10.1002/ana.21674 Srikanth, 2010, The location of white matter lesions and gait—a voxel-based study, Ann. Neurol., 67, 265, 10.1002/ana.21826 Vellas, 2014, Mapt study: a multidomain approach for preventing Alzheimer's disease: design and baseline data, J. Prev Alzheimers Dis., 1, 13 Wardlaw, 2013, Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration, Lancet Neurol., 12, 822, 10.1016/S1474-4422(13)70124-8 Zheng, 2011, Impact of white matter lesions on physical functioning and fall risk in older people: a systematic review, Stroke, 42, 2086, 10.1161/STROKEAHA.110.610360